First biosimilar mAb approved in Europe

Hospira's Inflectra (infliximab), which is a biosimilar to the reference biologic product, Remicade, has been approved by the EC for the treatment of inflammatory conditions.
Sep 13, 2013
By Pharmaceutical Technology Editors